C07C 65/03
Monocyclic and having all hydroxy or o-metal groups bound to the ring
Official title: monocyclic and having all hydroxy or O-metal groups bound to the ring
C07C65/03 (Monocyclic and having all hydroxy or o-metal groups bound to the ring) appears on 256 US grants and 277 published applications in this corpus.
Search patents in C07C- Granted patents
- 256
- Published applications
- 277
- Assignees
- 220
- Inventors
- 854
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 8 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 2 | 0 |
| 1991 | 5 | 0 |
| 1992 | 7 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 6 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 3 |
| 2003 | 1 | 3 |
| 2004 | 3 | 3 |
| 2005 | 1 | 3 |
| 2006 | 1 | 4 |
| 2007 | 2 | 5 |
| 2008 | 1 | 5 |
| 2009 | 4 | 5 |
| 2010 | 2 | 5 |
| 2011 | 0 | 10 |
| 2012 | 4 | 10 |
| 2013 | 10 | 8 |
| 2014 | 11 | 7 |
| 2015 | 7 | 14 |
| 2016 | 7 | 15 |
| 2017 | 15 | 17 |
| 2018 | 9 | 17 |
| 2019 | 18 | 14 |
| 2020 | 13 | 16 |
| 2021 | 12 | 24 |
| 2022 | 11 | 17 |
| 2023 | 11 | 20 |
| 2024 | 12 | 21 |
| 2025 | 11 | 16 |
| 2026 | 12 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Psilocybin analogs, salts, compositions, and methods of use15 Sep 2026US 12,735,386 B2Cybin IRL Limited
- Cocrystalline forms of FGFR3 inhibitors23 Jun 2026US 12,662,483 B2Eli Lilly and Company
- Salt form and crystal form of pyrazole substituted imidazo[1,2-a]quinoxaline derivative9 Jun 2026US 12,649,747 B2Ocumension Therapeutics (Suzhou) Co., Ltd.
- Pharmaceutically acceptable salts of sepiapterin26 May 2026US 12,637,465 B2PTC Therapeutics MP, Inc.
- Combination product comprising dicycloplatin and preparation method and use thereof26 May 2026US 12,637,487 B2Medoncare Pharmaceutical Co., Ltd.
- Cocrystalline forms of fgfr3 inhibitors1 Oct 2026US 2026/0297090 A1Eli Lilly and Company
- Salt form and crystal form of thienopyrimidine compound, and preparation method therefor and use thereof24 Sep 2026US 2026/0285874 A1Shandong Luye Pharmaceutical Co., Ltd.
- Psilocybin analogs, salts, compositions, and methods of use27 Aug 2026US 2026/0250246 A1Cybin IRL Limited
- Cocrystals of cortexolone 17-propionate and methods for their preparation6 Aug 2026US 2026/0226092 A1Farmabios S.P.A.
- Crystal forms of amino lipids30 Jul 2026US 2026/0217644 A1ModernaTX, Inc.
Most cited
By later US patents
- Crystalline forms of a purine derivative99US 8,889,861 B2Cyclacel Limited · 2014
- Nicotine salts, co-crystals, and salt co-crystal complexes50US 9,738,622 B2R. J. Reynolds Tobacco Company · 2017
- Salt forms of a xanthine compound44US 8,865,729 B2Boehringer Ingelheim International GmbH · 2014
- Water soluble salts of an NSAID with meglumine/glucamine39US 4,748,174 ATherapicon SRL · 1988
- Lipophilic quaternary ammonium salicylates, their use in cosmetics and in dermopharmacy38US 5,001,156 AL'oreal · 1991